BPC-157 (10mg)
Specifiche tecniche
| Purezza (HPLC) | ≥99% (HPLC) |
| Numero CAS | 137525-51-0 |
| Forma | White lyophilized powder |
| Conservazione | -20°C |
| Sequenza | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Peso molecolare | 1,419.53 g/mol |
| Forma salina | Acetate |
| Solubilità | Soluble in water, DMSO |
BPC-157 (10mg)
Prezzo di listino EUR · HU, SK, CZ, PL
- Eurozone (EUR)96,00 EUR
- Ungheria (HU)96,00 EUR≈ 38 400 Ft
- Slovacchia (SK)96,00 EUR
- Cechia (CZ)96,00 EUR≈ 2 400 Kč
- Polonia (PL)96,00 EUR≈ 408,00 zł
Stesso prezzo di listino in EUR per consegna in Ungheria, Slovacchia, Repubblica Ceca e Polonia. Pagamento in EUR.
HUF/CZK/PLN indicativi convertiti da EUR; la Slovacchia usa EUR. Tassi approssimativi. Pagamento in EUR.
Pentadecapeptide for regenerative research. Modulates VEGF and NO systems. 10mg vial, ≥99% HPLC purity.
Solo per ricerca di laboratorio.
Non destinato al consumo umano, uso veterinario o diagnostico.
From the Peptide Explorer
A 15-amino-acid gastric pentadecapeptide with remarkable stability in the GI tract. One of the most extensively studied peptides in regenerative research with over 100 publications spanning wound healing, angiogenesis, tendon repair, and cytoprotection.
Key Mechanisms
- ›VEGFR2 upregulation
- ›FAK-paxillin pathway activation
- ›ERK1/2 signaling
- ›NO system modulation
- ›Growth hormone receptor upregulation
Primary Research Areas
- ›Wound healing
- ›Tendon & ligament repair
- ›GI cytoprotection
- ›Angiogenesis
- ›Neuroprotection
Key Research Findings
- Accelerated tendon-to-bone healing in rat models (Chang et al., 2014)
- Promoted angiogenesis via VEGFR2 in endothelial cells (Hsieh et al., 2017)
- Demonstrated GI cytoprotective effects against NSAID damage (Sikiric et al., 2018)
Research Overview
A 15-amino-acid gastric pentadecapeptide with remarkable stability in the GI tract. One of the most extensively studied peptides in regenerative research with over 100 publications spanning wound healing, angiogenesis, tendon repair, and cytoprotection.
Origin: Derived from human gastric juice protein BPC
Mechanism of Action
- VEGFR2 upregulation
- FAK-paxillin pathway activation
- ERK1/2 signaling
- NO system modulation
- Growth hormone receptor upregulation
Primary Research Areas
- Wound healing
- Tendon & ligament repair
- GI cytoprotection
- Angiogenesis
- Neuroprotection
Key Published Findings
- Accelerated tendon-to-bone healing in rat models (Chang et al., 2014)
- Promoted angiogenesis via VEGFR2 in endothelial cells (Hsieh et al., 2017)
- Demonstrated GI cytoprotective effects against NSAID damage (Sikiric et al., 2018)
Research Protocol
Commonly studied routes: Subcutaneous, Oral. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized, 2-8°C reconstituted (3-4 weeks)
Important Notice
BPC-157 (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Specifiche di ricerca
Synthesized for strict analytical consistency. Verified via HPLC/MS.Vedi standard qualità →
Manipolazione e conservazione
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water, DMSO